Ryogen

Ryogen is a biotechnology company focused on the identification and patenting of genomic sequences with significant diagnostic and therapeutic potential. Founded by Nobel laureate James D. Watson and led by Valeria Poltorak, the company specializes in securing intellectual property for genes associated with high-impact diseases such as cancer, diabetes, and obesity. Ryogen's business model centers on licensing its extensive patent portfolio to pharmaceutical and diagnostic companies for further development. The company's portfolio includes patents related to protein tyrosine phosphatases and other critical genetic markers. By bridging the gap between genomic discovery and commercial application, Ryogen aims to facilitate the development of next-generation medical treatments.